Robert A Kratzke (Robert Kratzke)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Pseudomonas Aeruginosa

Tyrosine Kinase

Brain Metastases

Top Venues

International journal of molecular sciences

JCO oncology practice

Cancer chemotherapy and pharmacology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Libang Yang, Adam Gilbertsen, Blake Jacobson, Robert A Kratzke, Craig A Henke
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers. International journal of molecular sciences 25 (16) (2024)
Libang Yang, Adam Gilbertsen, Blake Jacobson, Robert A Kratzke, Craig A Henke
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers. International journal of molecular sciences 25 (16) (2024)
Libang Yang, Adam Gilbertsen, Blake Jacobson, Jenny Pham, Arpit Rao, Craig A Henke, Robert A Kratzke
SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer. International journal of molecular sciences 24 (15) (2023)
Amit A Kulkarni, Robert A Kratzke
A Turning Point for Mesothelioma Therapy. JCO oncology practice (2021)
Blake A Jacobson, Zeeshan Ahmad, Sierra Chen, Gabriella Waldusky, Maxwell Dillenburg, Emilia Stoian, Daniel A Cambron, Anil J Patel, Manish R Patel, Carston R Wagner, Robert A Kratzke
4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer. Investigational new drugs 39 (3) (2020)
Elizabeth A Fry, Gloria E Niehans, Robert A Kratzke, Fumitake Kai, Kazushi Inoue
Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53. International journal of molecular sciences 21 (21) (2020)
Zeeshan Ahmad, Blake A Jacobson, Mitchell W McDonald, Nicolas Vattendahl Vidal, Gabriel Vattendahl Vidal, Sierra Chen, Maxwell Dillenburg, Aniekan M Okon, Manish R Patel, Carston R Wagner, Robert A Kratzke
Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma. Cancer chemotherapy and pharmacology 85 (2) (2020)